RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
23andMe Holding Co. Stock

23andMe Holding Co. Stocks 2024

23andMe Holding Co. Stocks

475.98 M

Ticker

ME

ISIN

US90138Q1085

In 2024, 23andMe Holding Co. had 475.98 M outstanding stocks, a 5.42% change from the 451.5 M stocks in the previous year.

The 23andMe Holding Co. Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2029e475.98
2028e475.98
2027e475.98
2026e475.98
2025e475.98
2024475.98
2023451.5
2022361.5
202143.4
202038.5
201934.5
201834.5

23andMe Holding Co. shares outstanding

The number of shares was 23andMe Holding Co. in 2023 — This indicates how many shares 451.5 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue 23andMe Holding Co. earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates 23andMe Holding Co.'s earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of 23andMe Holding Co.’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating 23andMe Holding Co.'s prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

23andMe Holding Co. Aktienanalyse

What does 23andMe Holding Co. do?

23andMe Holding Co. is an American company for personalized genomics and health research. The company was founded in 2006 and is headquartered in Sunnyvale, California. The name of the company comes from the 23 chromosomes in the human genome and the English expression for "me". The main business of 23andMe is DNA analysis for consumers. Customers can send their DNA samples to the company, with tests being conducted on more than 30 genetic traits, uncovering disease risks, and creating family trees. 23andMe uses advanced sequencing technologies to analyze more than one million genetic variations in your genome. The DNA samples are tested based on single nucleotide polymorphisms (SNPs), which can provide information about disease risks, ethnic origins, and family health history. The results are then provided on an online platform where customers can view and share their DNA information. One unique aspect of 23andMe is that it also collects genetic information for research. 23andMe collaborates with various universities and research institutions to gather data for more complex studies. Customers can participate by anonymously sharing their genetic data for research purposes. 23andMe has many advantages, such as the ability to predict the risk of certain diseases. Based on your DNA, 23andMe can determine if there are altered genes in your body that are associated with specific diseases. However, the company emphasizes that this is not a diagnosis and should not replace medical advice. 23andMe also emphasizes that it supports customers in conversations with their doctors and gives them the opportunity to discuss the results with their doctors and relatives. In addition to DNA analysis, the company also offers a genetic report on your fitness traits. 23andMe also provides details on how to better understand your genetic information and what you can do to improve your health. In 2013, 23andMe underwent a regulatory investigation, which led to a significant restriction of its services. The company had to discontinue its health risk assessments for customers due to concerns from the FDA. The FDA was concerned that customers might make medical decisions based on 23andMe reports that may not necessarily be good for them. However, after many discussions with the FDA, the company decided to relaunch and is now an even more well-known and successful company. The company has more than 10 million customers worldwide and is continuously growing. An emotional incentive for consumers to use 23andMe is the desire to know where they come from and who their ancestors were. Nearly 50 percent of 23andMe customers have chosen to release their DNA information for research purposes. 23andMe has already contributed to various research initiatives that have made important contributions to genomics and precision medicine. Overall, 23andMe offers a unique experience for customers as it presents genomics and personal health data in an accessible way. It is also a significant contribution to research in the field. The company has achieved a lot despite regulatory challenges along the way. 23andMe Holding Co. ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating 23andMe Holding Co.'s Shares Outstanding

23andMe Holding Co.'s shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in 23andMe Holding Co.’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding 23andMe Holding Co.’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in 23andMe Holding Co.’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about 23andMe Holding Co. stock

How many stocks are there of 23andMe Holding Co.?

The current number of stocks of 23andMe Holding Co. is 475.98 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of 23andMe Holding Co. are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of 23andMe Holding Co. evolved in recent years?

The number of shares of 23andMe Holding Co. has increased by 5.42% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. 23andMe Holding Co. as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of 23andMe Holding Co.?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does 23andMe Holding Co. pay?

Over the past 12 months, 23andMe Holding Co. paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, 23andMe Holding Co. is expected to pay a dividend of 0 USD.

What is the dividend yield of 23andMe Holding Co.?

The current dividend yield of 23andMe Holding Co. is .

When does 23andMe Holding Co. pay dividends?

23andMe Holding Co. pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of 23andMe Holding Co.?

23andMe Holding Co. paid dividends every year for the past 0 years.

What is the dividend of 23andMe Holding Co.?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is 23andMe Holding Co. located?

23andMe Holding Co. is assigned to the 'Health' sector.

Wann musste ich die Aktien von 23andMe Holding Co. kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of 23andMe Holding Co. from 9/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did 23andMe Holding Co. pay the last dividend?

The last dividend was paid out on 9/27/2024.

What was the dividend of 23andMe Holding Co. in the year 2023?

In the year 2023, 23andMe Holding Co. distributed 0 USD as dividends.

In which currency does 23andMe Holding Co. pay out the dividend?

The dividends of 23andMe Holding Co. are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von 23andMe Holding Co.

Our stock analysis for 23andMe Holding Co. Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of 23andMe Holding Co. Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.